Two Sigma Investments’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-786,682
| Closed | -$9.72M | – | 3593 |
|
|
2024
Q4 | $9.72M | Sell |
786,682
-40,507
| -5% | -$464K | 0.02% | 765 |
|
|
2024
Q3 | $9.41M | Buy |
827,189
+63,626
| +8% | +$639K | 0.02% | 789 |
|
|
2024
Q2 | $5.45M | Buy |
763,563
+307,076
| +67% | +$2.35M | 0.01% | 973 |
|
|
2024
Q1 | $3.06M | Sell |
456,487
-118,352
| -21% | -$814K | 0.01% | 1221 |
|
|
2023
Q4 | $3.74M | Buy |
574,839
+537,530
| +1,441% | +$3.46M | 0.01% | 1136 |
|
|
2023
Q3 | $352K | Buy |
+37,309
| New | +$449K | ﹤0.01% | 2429 |
|
|
2023
Q2 | – | Sell |
-76,068
| Closed | -$1.43M | – | 3336 |
|
|
2023
Q1 | $1.43M | Buy |
+76,068
| New | +$1.25M | ﹤0.01% | 1650 |
|
|
2022
Q3 | – | Sell |
-47,953
| Closed | -$732K | – | 2911 |
|
|
2022
Q2 | $732K | Buy |
+47,953
| New | +$709K | ﹤0.01% | 1675 |
|
|
2022
Q1 | – | Sell |
-22,819
| Closed | -$666K | – | 4584 |
|
|
2021
Q4 | $666K | Sell |
22,819
-82,500
| -78% | -$2.36M | ﹤0.01% | 2953 |
|
|
2021
Q3 | $2.27M | Buy |
105,319
+14,800
| +16% | +$357K | 0.01% | 1873 |
|
|
2021
Q2 | $2.32M | Sell |
90,519
-117,374
| -56% | -$2.51M | 0.01% | 1748 |
|
|
2021
Q1 | $3.79M | Buy |
207,893
+74,101
| +55% | +$1.23M | 0.01% | 1242 |
|
|
2020
Q4 | $1.54M | Buy |
+133,792
| New | +$1.22M | ﹤0.01% | 1674 |
|
|
2020
Q1 | – | Sell |
-269,192
| Closed | -$2.06M | – | 3948 |
|
|
2019
Q4 | $2.06M | Buy |
+269,192
| New | +$1.57M | 0.01% | 1559 |
|
|
2019
Q2 | – | Sell |
-50,831
| Closed | -$216K | – | 3740 |
|
|
2019
Q1 | $216K | Sell |
50,831
-5,886
| -10% | -$24K | ﹤0.01% | 2781 |
|
|
2018
Q4 | $233K | Buy |
56,717
+3,098
| +6% | +$16.2K | ﹤0.01% | 2616 |
|
|
2018
Q3 | $368K | Buy |
+53,619
| New | +$318K | ﹤0.01% | 2643 |
|
Other funds holding CDMO
Two Sigma Investments's CDMO Position: Q1 2025 in Review
Two Sigma Investments sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 786,682 shares — an estimated $9.72M sold.
Two Sigma Investments first reported a position in CDMO in Q3 2018 and held it in 17 quarters. The position peaked at $9.72M in Q4 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.
- Two Sigma Investments reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Two Sigma Investments sold 786,682 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $9.72M.
- Two Sigma Investments first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2018 and held it in 17 quarters.
- Two Sigma Investments's Avid Bioservices, Inc. Common Stock position peaked at $9.72M in Q4 2024.
- 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.
Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.